- Home
- REPL vs CLFD Comparison
REPL vs CLFD Comparison
Compare REPL & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- CLFD
- Stock Information
- Founded
- REPL 2015
- CLFD 1979
- Country
- REPL United States
- CLFD United States
- Employees
- REPL N/A
- CLFD N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- CLFD Telecommunications Equipment
- Sector
- REPL Health Care
- CLFD Utilities
- Exchange
- REPL Nasdaq
- CLFD Nasdaq
- Market Cap
- REPL 547.0M
- CLFD 608.6M
- IPO Year
- REPL 2018
- CLFD N/A
- Fundamental
- Price
- REPL $5.71
- CLFD $33.68
- Analyst Decision
- REPL Hold
- CLFD Strong Buy
- Analyst Count
- REPL 9
- CLFD 1
- Target Price
- REPL $7.00
- CLFD $50.00
- AVG Volume (30 Days)
- REPL 2.1M
- CLFD 141.1K
- Earning Date
- REPL 11-11-2025
- CLFD 11-06-2025
- Dividend Yield
- REPL N/A
- CLFD N/A
- EPS Growth
- REPL N/A
- CLFD N/A
- EPS
- REPL N/A
- CLFD 0.01
- Revenue
- REPL N/A
- CLFD $179,319,000.00
- Revenue This Year
- REPL N/A
- CLFD $11.41
- Revenue Next Year
- REPL $408.25
- CLFD $13.55
- P/E Ratio
- REPL N/A
- CLFD $2,384.30
- Revenue Growth
- REPL N/A
- CLFD 5.72
- 52 Week Low
- REPL $2.68
- CLFD $23.78
- 52 Week High
- REPL $17.00
- CLFD $46.76
- Technical
- Relative Strength Index (RSI)
- REPL 46.92
- CLFD 47.64
- Support Level
- REPL $5.60
- CLFD $32.08
- Resistance Level
- REPL $6.15
- CLFD $34.79
- Average True Range (ATR)
- REPL 0.33
- CLFD 1.09
- MACD
- REPL 0.06
- CLFD 0.42
- Stochastic Oscillator
- REPL 32.48
- CLFD 66.91
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.